Artal Group S.A. - JOUNCE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,913,000
-38.6%
150,000
-25.0%
0.03%
-46.3%
Q3 2017$3,116,000
-11.2%
200,000
-20.0%
0.05%
-11.5%
Q2 2017$3,508,000
-46.8%
250,000
-16.7%
0.06%
-58.2%
Q1 2017$6,597,000300,0000.15%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders